logo

Matinas Biopharma Holdings, Inc. (MTNB)



Trade MTNB now with
  Date
  Headline
3/8/2022 6:52:56 AM Matinas BioPharma Q4 Loss Attributable To Shareholders $6.7 Mln Or $0.03/Shr Vs Loss $6.6 Mln Or $0.03/Shr Last Year
11/8/2021 6:44:32 AM Matinas BioPharma Q3 Loss Attributable To Shareholders $6.8 Mln Or $0.03/Shr Vs Loss $5.7 Mln Or $0.03/Shr Last Eyar
8/16/2021 7:25:55 AM Matinas BioPharma Announces Issuance Of U.S. Patent Protecting MAT2203 To Treat Or Prevent Cryptococcus Infections
2/1/2021 6:31:45 AM Matinas:Primary Endpoint Of Percent Change From Baseline To End Of Treatment In TG Did Not Meet Statistical Significance